Cite
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)
MLA
Daniel M. Labow, et al. “Recurrent Pancreatic Carcinoma and Cholangiocarcinoma: 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (PET/CT).” Abdominal Imaging, vol. 36, no. 4, Apr. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e88b2ee3e0a15b1656bcff80c1ac0b8&authtype=sso&custid=ns315887.
APA
Daniel M. Labow, Sasan Roayaie, Lale Kostakoglu, Steven Peti, Sivan Golan, Katherine L. Cameron, & William L. Simpson. (2011). Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdominal Imaging, 36(4).
Chicago
Daniel M. Labow, Sasan Roayaie, Lale Kostakoglu, Steven Peti, Sivan Golan, Katherine L. Cameron, and William L. Simpson. 2011. “Recurrent Pancreatic Carcinoma and Cholangiocarcinoma: 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (PET/CT).” Abdominal Imaging 36 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e88b2ee3e0a15b1656bcff80c1ac0b8&authtype=sso&custid=ns315887.